Huberman Lab cover image

Peptide & Hormone Therapies for Health, Performance & Longevity | Dr. Craig Koniver

Huberman Lab

NOTE

Optimize Growth with Synergistic Peptides

Combining growth hormone-releasing peptides, such as semerelin and GHRP6, with BPC-157 enhances the efficiency of growth hormone binding due to BPC's ability to upregulate growth hormone receptors. This synergy allows for reduced dosages of growth hormone-releasing peptides while achieving similar results. BPC-157, particularly in oral forms, shows promise as an anti-inflammatory agent, especially for gastrointestinal issues like Crohn's disease, ulcerative colitis, and leaky gut, due to its stability and effectiveness in the gut environment.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner